Posted By admin Posted On

Stem Cells Fight Brain Cancer In Important New Study

A team of esteemed scientists looking for a way to fight brain cancer used stem cells that were genetically engineered in their laboratory on afflicted mice. Through this method, toxins attacked the cancer cells while keeping the other cells on board as healthy as ever.

In other words, this team was able to enlist “genetic engineering to make stem cells that spewed out cancer-killing toxins, but, crucially, were also able to resist the effects of the poison they were producing,” says the BBC.

This extremely major breakthrough in the search for a cure for this kind of cancer was published in a prominent medical journal. The study came about after many years of research in this complicated field of medicine.

Stem Cells Fight Brain Cancer In Important New Study

The study, taking place at Massachusetts General Hospital and Harvard Stem Cell Institute, was led by Dr. Khalid Shah. Dr. Shah remarked, “Cancer-killing toxins have been used with great success in a variety of blood cancers, but they don’t work as well in solid tumors because the cancers aren’t as accessible.”

He added, “A few years ago we recognized that the stem cell could be used to continuously deliver these therapeutic toxins to tumors in the brain, but first we needed to genetically engineer stem cells that could resist being killed themselves by the toxins…. Now, we have toxin-resistant cells that can make and release cancer-killing drugs.”

With that, Dr. Shah and his crew will go on to develop these particular cells. They were and will continue to be tested on mice who are struggling with all sorts of brain tumors after which time clinical trials will start. That will happen within five years time.

That said, it is not surprising his breakthrough study is garnering plenty of attention.

In fact, senior science information manager for Cancer Research UK Nell Barrie, dubbed the work “ingenious.”

In addition, Chris Mason, who is professor of regenerative medicine at University College London, called out the research as a way that “signals the beginning of the next wave of therapies.” in fighting brain cancer.

Indeed, this approach does seem to be the start of a new approach to beat the deadly disease.